Immunic, Inc. (IMUX)
6.97
-0.13
(-1.83%)
USD |
NASDAQ |
Oct 16, 16:00
6.955
-0.02
(-0.22%)
After-Hours: 20:00
Immunic Net Income (TTM) : -111.57M for June 30, 2026
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -111.57M |
| March 31, 2026 | -104.29M |
| December 31, 2025 | -97.17M |
| September 30, 2025 | -103.05M |
| June 30, 2025 | -101.84M |
| March 31, 2025 | -96.40M |
| December 31, 2024 | -100.51M |
| September 30, 2024 | -96.90M |
| June 30, 2024 | -95.30M |
| March 31, 2024 | -97.92M |
| December 31, 2023 | -93.61M |
| September 30, 2023 | -128.51M |
| June 30, 2023 | -126.97M |
| March 31, 2023 | -124.87M |
| December 31, 2022 | -120.41M |
| September 30, 2022 | -85.12M |
| June 30, 2022 | -83.19M |
| March 31, 2022 | -79.22M |
| December 31, 2021 | -92.94M |
| September 30, 2021 | -82.92M |
| June 30, 2021 | -76.54M |
| March 31, 2021 | -70.06M |
| December 31, 2020 | -44.02M |
| September 30, 2020 | -40.55M |
| June 30, 2020 | -35.85M |
| Date | Value |
|---|---|
| March 31, 2020 | -39.11M |
| December 31, 2019 | -34.93M |
| September 30, 2019 | -32.05M |
| June 30, 2019 | -25.64M |
| March 31, 2019 | -13.59M |
| December 31, 2018 | -23.67M |
| September 30, 2018 | -33.44M |
| June 30, 2018 | -44.13M |
| March 31, 2018 | -53.86M |
| December 31, 2017 | -52.08M |
| September 30, 2017 | -49.22M |
| June 30, 2017 | -46.92M |
| March 31, 2017 | -43.98M |
| December 31, 2016 | -40.97M |
| September 30, 2016 | -39.09M |
| June 30, 2016 | -41.22M |
| March 31, 2016 | -46.85M |
| December 31, 2015 | -52.02M |
| September 30, 2015 | -56.12M |
| June 30, 2015 | -56.62M |
| March 31, 2015 | -51.68M |
| December 31, 2014 | -47.67M |
| September 30, 2014 | -43.97M |
| June 30, 2014 | -40.20M |
| March 31, 2014 | -31.69M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 380.48M |
| Sionna Therapeutics, Inc. | -97.38M |
| Alnylam Pharmaceuticals, Inc. | 807.99M |
| Anika Therapeutics, Inc. | -3.121M |
| Savara, Inc. | -139.31M |